Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 11 Jul 2024

Case report: Pathological complete response to neoadjuvant brigatinib in stage III non-small cell lung cancer with ALK rearrangement

in Thoracic Oncology

Hayoung Seong
Soo Han Kim
Mi Hyun Kim
Jeong Su Cho
Ahrong Kim
Jung Seop Eom

Frontiers in Oncology

doi 10.3389/fonc.2024.1343238

2,055 views

Review

Published on 11 Jul 2024

Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives

in Thoracic Oncology

Hang Zhang
Yingying Zhang
Yingying Zhu
Tian Dong
Zheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1387345

4,465 views
5 citations

Case Report

Published on 09 Jul 2024

A case report of recurrent testicular germ cell tumor in a patient with a history of primary pulmonary germ cell tumor and a review of the literature

in Thoracic Oncology

Jian Tan
Jinfeng Wu
Runqiang Yuan
Wei Li
Linfeng Li
Hongxing Huang
Yangbai Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1361380

2,491 views

Systematic Review

Published on 09 Jul 2024

Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis

in Thoracic Oncology

Giulia Pasello
Alberto Pavan
Mattia De Nuzzo
Stefano Frega
Alessandra Ferro
Alessandro Dal Maso
Laura Bonanno
Valentina Guarneri
Fabio Girardi

Frontiers in Oncology

doi 10.3389/fonc.2024.1415470

4,517 views
5 citations

Original Research

Published on 09 Jul 2024

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study

in Thoracic Oncology

Marco Sposito
Lorenzo Belluomini
Riccardo Nocini
Jessica Insolda
Ilaria Mariangela Scaglione
Jessica Menis
Michele Simbolo
Antonio Lugini
Federica Buzzacchino
Francesco Verderame

Frontiers in Oncology

doi 10.3389/fonc.2024.1436588

6,792 views
13 citations

Original Research

Published on 08 Jul 2024

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

in Thoracic Oncology

Shujing Shen
Xingya Li
Sanxing Guo
Liang Xu
Ningning Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1391828

2,144 views
6 citations

Case Report

Published on 08 Jul 2024

Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib

in Thoracic Oncology

Akihiro Nishiyama
Shigeki Sato
Hiroyuki Sakaguchi
Hiroshi Kotani
Kaname Yamashita
Koushiro Ohtsubo
Shigeki Nanjo
Seiji Yano
Keishi Mizuguchi
Hiroko Ikeda

Frontiers in Oncology

doi 10.3389/fonc.2024.1374594

3,510 views
1 citation

Case Report

Published on 08 Jul 2024

Case report: Pulmonary sarcomatoid carcinoma demonstrating rapid growth on follow-up CT

in Thoracic Oncology

Li Tu
Hong Xie
Lianshan Zhan
Yushi Yang
Tingting Chen
Na Hu
Xiaojun Du
Shi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1393203

2,571 views
2 citations

Case Report

Published on 08 Jul 2024

Repeating late-phase pseudo-progression in a patient with non-small cell lung cancer treated with long-term nivolumab monotherapy; a case report

in Thoracic Oncology

Rikako Ebisuda
Naoki Furuya
Takeo Inoue
Shotaro Kaneko
Yu Numata
Yusuke Shinozaki
Masamichi Mineshita

Frontiers in Oncology

doi 10.3389/fonc.2024.1353698

2,439 views
1 citation

Original Research

Published on 05 Jul 2024

Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study

in Thoracic Oncology

Bo Fan
Xiaoyan Sun
Weijie Han
Yimin Zou
Fei Chen
Fen Lan
Wen Li
Yanxiong Mao

Frontiers in Oncology

doi 10.3389/fonc.2024.1398357

3,025 views
9 citations

Review

Published on 04 Jul 2024

Comparative analysis of medical glue and positioning hooks for preoperative localization of pulmonary nodules

in Thoracic Oncology

Haowen Wang
Min Deng
Dexin Cheng
Rui Feng
Hanbo Liu
Tingyang Hu
Dongdong Liu
Cheng Chen
Peilin Zhu
Jian Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1392213

1,858 views
2 citations

Original Research

Published on 04 Jul 2024

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis

in Thoracic Oncology

Xueming Xia
Wei Du
Yan Zhang
Yanying Li
Min Yu
Yongmei Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1354854

2,375 views

Systematic Review

Published on 04 Jul 2024

The efficacy and safety of immunotherapy as first−line treatment for extensive-stage small cell lung cancer: evaluating based on reconstructed individual patient data

in Thoracic Oncology

Shuang Zhang
Shuang Li
Ying Cheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1371313

3,298 views
2 citations

Original Research

Published on 02 Jul 2024

The diagnostic value of CT-based radiomics nomogram for solitary indeterminate smoothly marginated solid pulmonary nodules

in Thoracic Oncology

Chengzhou Zhang
Huihui Zhou
Mengfei Li
Xinyu Yang
Jinling Liu
Zhengjun Dai
Heng Ma
Ping Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1427404

1,919 views

Case Report

Published on 02 Jul 2024

Case report: Response to tepotinib in Chinese non-small cell lung cancer patients harboring METex14 skipping with varying features

in Thoracic Oncology

Yan Meng
Weiping Zhou
Chenping Li
Xiangjie Zhou
Xiao Li
Liang Li
Qiye Fu
Jue Huang
Yali Yue
Xuguang Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1383964

2,777 views
1 citation

Original Research

Published on 01 Jul 2024

Investigating esophageal sarcomatoid carcinoma and its comparison with esophageal squamous cell carcinoma on clinicopathological characteristics, prognosis, and radiomics features: a retrospective study

in Thoracic Oncology

Binbin Hu
Kejia Zhao
Yushang Yang
Yi Zhang
Guihong Liu
Haiyan Zeng
Bingwen Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1398982

2,375 views
3 citations

Original Research

Published on 01 Jul 2024

Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cells

in Thoracic Oncology

Hanna Sentek
Annika Braun
Bettina Budeus
Diana Klein

Frontiers in Oncology

doi 10.3389/fonc.2024.1406268

3,521 views
11 citations

Original Research

Published on 01 Jul 2024

Nomogram for predicting invasive lung adenocarcinoma in small solitary pulmonary nodules

in Thoracic Oncology

Mengchao Xue
Rongyang Li
Junjie Liu
Ming Lu
Zhenyi Li
Huiying Zhang
Hui Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1334504

2,701 views
1 citation

Original Research

Published on 25 Jun 2024

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

in Thoracic Oncology

Ni Sun
Ru Li
Haiyi Deng
Qingyang Li
Jiaxi Deng
Yue Zhu
Wenwei Mo
Wenhui Guan
Minjuan Hu
Ming Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1372532

2,788 views
1 citation

Original Research

Published on 25 Jun 2024

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy

in Thoracic Oncology

Min Zhang
Liang Zhu
Sibei Liang
Zhirong Mao
Xiaolin Li
Lingge Yang
Yan Yang
Kai Wang
Pingli Wang
Weiyu Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1411436

3,164 views
3 citations

Case Report

Published on 24 Jun 2024

Case report: Precise NGS and combined bevacizumab promote durable response in ALK-positive lung adenocarcinoma with multiple-line ALK-TKI resistance

in Thoracic Oncology

Jin Xiong
Lei Xia

Frontiers in Oncology

doi 10.3389/fonc.2024.1419306

2,123 views
1 citation

Original Research

Published on 24 Jun 2024

Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer

in Thoracic Oncology

Shixin Ma
Lunqing Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1396843

2,895 views
15 citations

Original Research

Published on 21 Jun 2024

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

in Thoracic Oncology

Blake J. McKinley
Tanmayi S. Pai
Emily B. Wolf
Shenduo Li
Guilherme Sacchi de Camargo Correia
Yujie Zhao
Rami Manochakian
Yanyan Lou

Frontiers in Oncology

doi 10.3389/fonc.2024.1417175

3,637 views
1 citation

Review

Published on 21 Jun 2024

Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer

in Thoracic Oncology

Xiaochen Wang
Lu Bai
Linghui Kong
Zhijuan Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1411731

4,229 views
6 citations

1,976 articles

articles

Case report: Pathological complete response to neoadjuvant brigatinib in stage III non-small cell lung cancer with ALK rearrangement

Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives

A case report of recurrent testicular germ cell tumor in a patient with a history of primary pulmonary germ cell tumor and a review of the literature

Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib

Case report: Pulmonary sarcomatoid carcinoma demonstrating rapid growth on follow-up CT

Repeating late-phase pseudo-progression in a patient with non-small cell lung cancer treated with long-term nivolumab monotherapy; a case report

Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study

Comparative analysis of medical glue and positioning hooks for preoperative localization of pulmonary nodules

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis

The efficacy and safety of immunotherapy as first−line treatment for extensive-stage small cell lung cancer: evaluating based on reconstructed individual patient data

The diagnostic value of CT-based radiomics nomogram for solitary indeterminate smoothly marginated solid pulmonary nodules

Case report: Response to tepotinib in Chinese non-small cell lung cancer patients harboring METex14 skipping with varying features

Investigating esophageal sarcomatoid carcinoma and its comparison with esophageal squamous cell carcinoma on clinicopathological characteristics, prognosis, and radiomics features: a retrospective study

Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cells

Nomogram for predicting invasive lung adenocarcinoma in small solitary pulmonary nodules

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy

Case report: Precise NGS and combined bevacizumab promote durable response in ALK-positive lung adenocarcinoma with multiple-line ALK-TKI resistance

Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer